Clinical Scorecard: Are the benefits observed with the Endo-App genuinely long-lasting?

At a Glance

Key Highlights

• Modest mean pain reduction of 0.80 points at 3 months and 0.85 points at 6–7 months
• Significant decline in sick days and days requiring medical assistance
• Lack of a clearly characterized longitudinal trajectory due to participant attrition
• No established threshold for clinically important benefit in endometriosis-related pain
• Nominally significant results may not meet multiplicity adjustment criteria

Guideline-Based Recommendations

Diagnosis

• Consider comprehensive assessment of pain phenotype including fibromyalgia and central sensitization

Management

• Utilize multimodal management approaches including analgesics and hormonal therapies

Monitoring & Follow-up

• Conduct longitudinal assessments to evaluate persistent changes in pain

Risks

• Be cautious of expectancy effects, natural symptom variation, and treatment modifications

Patient & Prescribing Data

Individuals with chronic pain associated with endometriosis

Analgesic exposure varies; treatment days do not reflect total medication exposure

Clinical Best Practices

• Implement responder analyses based on predefined thresholds for pain reduction
• Adjust for multiplicity in analyses to ensure robust evaluation of outcomes
• Document concomitant treatments to avoid confounding effects

Related Resources & Content

• Nigdelis et al. study
• Clinical significance of pain reduction thresholds
• Endometriosis pain management guidelines